| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |